JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

A

115.41

+1%↑

VEEV

160.84

+3.11%↑

Search

Atossa Therapeutics Inc

Closed

5.69 0.35

Overview

Share price change

24h

Current

Min

5.61

Max

5.6899999999999995

Key metrics

By Trading Economics

Income

-2.2M

-11M

Employees

16

EBITDA

-2.7M

-11M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+246.49% upside

Market Stats

By TradingEconomics

Market Cap

4.8M

53M

Previous open

5.34

Previous close

5.69

Technical Score

By Trading Central

Confidence

Bullish Evidence

Atossa Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

16 sty 2026, 23:29 UTC

Hot Stocks

Stocks to Watch: Atossa Therapeutics, Union Pacific

Peer Comparison

Price change

Atossa Therapeutics Inc Forecast

Price Target

By TipRanks

246.49% upside

12 Months Forecast

Average 19.75 USD  246.49%

High 25 USD

Low 10 USD

Based on 4 Wall Street analysts offering 12 month price targets forAtossa Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

4 ratings

4

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

0.7955 / 0.898Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Weak Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

help-icon Live chat